Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Not yet recruiting 2Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER_GOV 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Colorectal Neoplasms 1057Stomach Neoplasms 802Carcinoma, Hepatocellular 785Pancreatic Neoplasms 577Rectal Neoplasms 449Colonic Neoplasms 405Esophageal Neoplasms 363Liver Neoplasms 225Esophageal Squamous Cell Carcinoma 144Neoplasms 134Cholangiocarcinoma 129Neoplasm Metastasis 117Breast Neoplasms 117Gastrointestinal Neoplasms 105Lung Neoplasms 76Biliary Tract Neoplasms 73Recurrence 61Prostatic Neoplasms 52Ovarian Neoplasms 49Barrett Esophagus 47Carcinoma, Non-Small-Cell Lung 44Anastomotic Leak 43Bile Duct Neoplasms 42Gastrointestinal Stromal Tumors 40Gallbladder Neoplasms 40Head and Neck Neoplasms 38Digestive System Neoplasms 35Anus Neoplasms 34Colonic Polyps 33Adenocarcinoma Of Esophagus 32

Interventions

tesetaxel 1GC1118 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Adenocarcinoma of the Stomach × Gastrointestinal × Clear all
NCT04077255 2022-11-30

EGFR-targeted Therapy for Gastric Cancer

National Cancer Center, Korea

Phase 2 Unknown
19 enrolled
Gastrointestinal

Adenocarcinoma of the Stomach

NCT01095120 2012-03-15

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

Genta Incorporated

Phase 2 Unknown
27 enrolled
Gastrointestinal

Adenocarcinoma of the Stomach

Data powered by HemOnc (CC BY 4.0) Colophon âš¡